Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Recombinant DNA Technology Market: By Product: Medical, Non-Medical; By Component: Expression System, Cloning Vector; By Application: Food and Agriculture, Others; By End Use; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Recombinant DNA Technology Market Outlook
The global recombinant DNA Technology market attained a value of about USD 608 billion in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 6.8% to reach nearly USD 902 billion by 2026.
Advancements in Technology Owing to Research and Development (R&D) is Expected to Augment the Market Growth
The growing research and development (R&D) activities to treat life threatening diseases like cancer, diabetes, and other immunodeficiency diseases are expected to augment the market growth of recombinant DNA technology. Technology in collaboration with medicine has made it possible to treat diseases by inserting new or healthy genes in replacement of damaged or diseased genes in the human body.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Recombinant DNA technology has allowed scientists to treat diabetes by developing human insulin by using bacteria as the host cell, with the drug produced through microbes thought to be more efficient than the traditional drug. Such developments are expected to aid the market growth. Moreover, advancements in recombinant technologies have also led to the development of gene therapies, used in the treatment of genetic diseases, which is further anticipated to bolster the recombinant DNA industry in the coming years.
Growing Use of Recombinant DNA Technology to Produce Transgenic Animals to Aid the Market Growth
The recombinant DNA technology can be applied to animals to produce transgenic animals. Transgenic animals provide tremendous opportunities to study gene regulation and disease. This is expected to strengthen the research and development (R&D) sector and, thereby, aid the market growth of recombinant DNA technology. Transgenic animals may be genetically modified for the production of pharmaceuticals and vaccine, thus, bolstering industrial demand for recombinant DNA technology due to a heightened demand for effective vaccines and new drugs globally.
Recombinant DNA Technology : Industry Definition and Segmentation
Recombinant DNA technology (rDNA), also known as genetic engineering, is the technique in which the DNA is cut into small fragments and the joined together with different fragments taken from different organisms to form a recombinant DNA. It comprises altering genetic material outside an organism to obtain desired and enhanced results in living organisms.
Based on product, the market is divided into:
- Medical
- Therapeutic Agent
- Human Protein
- Vaccine
- Non-Medical
- Biotech Crops
- Speciality Chemicals
- Others
On the basis of component, the market is segmented into:
- Expression System
- Mammalian
- Bacteria
- Yeast
- Baculovirus/Insect
- Cloning Vector
Based on application, the market is divided into:
- Food and Agriculture
- Health and Disease
- Human
- Animal
- Environment
- Others
On the basis of end use, the market is categorised into:
- Biotechnology and Pharmaceutical Companies
- Academic and Government Research Institutions
- Others
The EMR report looks into the regional markets of recombinant DNA technology like North America, Europe, Latin America, the Asia Pacific, and the Middle East and Africa.
Use of Recombinant DNA technology in Food & Agricultural Sector to Surge Industrial Growth
Recombinant DNA technology has shown promising results in the agricultural sector in the production of genetically modified crops. The wide availability of genetically modified foods in the market owing to increased overall production of crops and reduced used of herbicides and insecticides used by farmers has been strengthening the market growth of recombinant DNA technology. The technology has introduced herbicide bacterial genes into the DNA of certain crops like wheat, soybean, cotton, and rice, making the plant resistant to weeds and insects and making the yield toxic free. This is supporting agricultural productivity and, thus, increasing the demand for recombinant DNA technology. The added benefit of reduced costs with the use of recombinant DNA technology in the agricultural sector is expected to further propel the industrial growth.
Moreover, the cultivation of vitamin-A rich golden rice using recombinant DNA technology to treat malnourished children is expected to further invigorate the market growth in the coming years. Further, with the rising research and development activities related to genetically modified crops, these crops can possess the ability to withstand adverse environmental conditions, such as drought and extreme heat conditions. This is anticipated to provide further growth opportunities for the recombinant DNA technology industry, especially with the growing concerns about climate change and global warming.
Key Industry Players in the Global Recombinant DNA Technology Market
The report presents a detailed analysis of the following key players in the global recombinant DNA technology market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions.
- Sanofi
- Amgen Inc.
- Genentech Inc.
- GenScript
- Profacgen
- Others
The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2016-2020 |
| Forecast Period | 2021-2026 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Component, Application, End Use, Region |
| Breakup by Product | Medical, Non-Medical |
| Breakup by Component | Expression System, Cloning Vector |
| Breakup by Application | Food and Agriculture, Health and Disease, Environment, Others |
| Breakup by End Use | Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Sanofi, Amgen Inc., Genentech Inc., GenScript, Profacgen., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Recombinant DNA Technology Market Analysis
8.1 Key Industry Highlights
8.2 Global Recombinant DNA Technology Historical Market (2016-2020)
8.3 Global Recombinant DNA Technology Market Forecast (2021-2026)
8.4 Global Recombinant DNA Technology Market by Product
8.4.1 Medical
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.1.4 Breakup by Type
8.4.1.4.1 Therapeutic Agent
8.4.1.4.1.1 Market Share
8.4.1.4.1.2 Historical Trend (2016-2020)
8.4.1.4.1.3 Forecast Trend (2021-2026)
8.4.1.4.2 Human Protein
8.4.1.4.2.1 Market Share
8.4.1.4.2.2 Historical Trend (2016-2020)
8.4.1.4.2.3 Forecast Trend (2021-2026)
8.4.1.4.3 Vaccine
8.4.1.4.3.1 Market Share
8.4.1.4.3.2 Historical Trend (2016-2020)
8.4.1.4.3.3 Forecast Trend (2021-2026)
8.4.2 Non-Medical
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.4.2.4 Breakup by Type
8.4.2.4.1 Biotech Crops
8.4.2.4.1.1 Market Share
8.4.2.4.1.2 Historical Trend (2016-2020)
8.4.2.4.1.3 Forecast Trend (2021-2026)
8.4.2.4.2 Speciality Chemicals
8.4.2.4.2.1 Market Share
8.4.2.4.2.2 Historical Trend (2016-2020)
8.4.2.4.2.3 Forecast Trend (2021-2026)
8.4.2.4.3 Others
8.5 Global Recombinant DNA Technology Market by Component
8.5.1 Expression System
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.1.4 Breakup by Type
8.5.1.4.1 Mammalian
8.5.1.4.1.1 Market Share
8.5.1.4.1.2 Historical Trend (2016-2020)
8.5.1.4.1.3 Forecast Trend (2021-2026)
8.5.1.4.2 Bacteria
8.5.1.4.2.1 Market Share
8.5.1.4.2.2 Historical Trend (2016-2020)
8.5.1.4.2.3 Forecast Trend (2021-2026)
8.5.1.4.3 Yeast
8.5.1.4.3.1 Market Share
8.5.1.4.3.2 Historical Trend (2016-2020)
8.5.1.4.3.3 Forecast Trend (2021-2026)
8.5.1.4.4 Baculovirus/Insect
8.5.1.4.4.1 Market Share
8.5.1.4.4.2 Historical Trend (2016-2020)
8.5.1.4.4.3 Forecast Trend (2021-2026)
8.5.2 Cloning Vector
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.6 Global Recombinant DNA Technology Market by Application
8.6.1 Food and Agriculture
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Health and Disease
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.2.4 Breakup by Type
8.6.2.4.1 Human
8.6.2.4.1.1 Market Share
8.6.2.4.1.2 Historical Trend (2016-2020)
8.6.2.4.1.3 Forecast Trend (2021-2026)
8.6.2.4.2 Animal
8.6.2.4.2.1 Market Share
8.6.2.4.2.2 Historical Trend (2016-2020)
8.6.2.4.2.3 Forecast Trend (2021-2026)
8.6.3 Environment
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2016-2020)
8.6.3.3 Forecast Trend (2021-2026)
8.6.4 Others
8.1 Global Recombinant DNA Technology Market by End Use
8.1.1 Biotechnology and Pharmaceutical Companies
8.1.1.1 Market Share
8.1.1.2 Historical Trend (2016-2020)
8.1.1.3 Forecast Trend (2021-2026)
8.1.2 Academic and Government Research Institutes
8.1.2.1 Market Share
8.1.2.2 Historical Trend (2016-2020)
8.1.2.3 Forecast Trend (2021-2026)
8.1.3 Others
8.2 Global Recombinant DNA Technology Market by Region
8.2.1 Market Share
8.2.1.1 North America
8.2.1.2 Europe
8.2.1.3 Asia Pacific
8.2.1.4 Latin America
8.2.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Sanofi
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Amgen Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Genentech Inc.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 GenScript
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Profacgen.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Recombinant DNA Technology Market: Key Industry Highlights, 2016 and 2026
2. Global Recombinant DNA Technology Historical Market: Breakup by Product (USD Billion), 2016-2020
3. Global Recombinant DNA Technology Market Forecast: Breakup by Product (USD Billion), 2016-2020
4. Global Recombinant DNA Technology Historical Market: Breakup by Component Type (USD Billion), 2016-2020
5. Global Recombinant DNA Technology Market Forecast: Breakup by Component Type (USD Billion), 2021-2026
6. Global Recombinant DNA Technology Historical Market: Breakup by Application (USD Billion), 2016-2020
7. Global Recombinant DNA Technology Market Forecast: Breakup by Application (USD Billion), 2021-2026
8. Global Recombinant DNA Technology Historical Market: Breakup by End-Use (USD Billion), 2016-2020
9. Global Recombinant DNA Technology Market Forecast: Breakup by End-Use (USD Billion), 2021-2026
10. Global Recombinant DNA Technology Historical Market: Breakup by Region (USD Billion), 2016-2020
11. Global Recombinant DNA Technology Market Forecast: Breakup by Region (USD Billion), 2021-2026
12. North America Recombinant DNA Technology Historical Market: Breakup by Country (USD Billion), 2016-2020
13. North America Recombinant DNA Technology Market Forecast: Breakup by Country (USD Billion), 2021-2026
14. Europe Recombinant DNA Technology Historical Market: Breakup by Country (USD Billion), 2016-2020
15. Europe Recombinant DNA Technology Market Forecast: Breakup by Country (USD Billion), 2021-2026
16. Asia Pacific Recombinant DNA Technology Historical Market: Breakup by Country (USD Billion), 2016-2020
17. Asia Pacific Recombinant DNA Technology Market Forecast: Breakup by Country (USD Billion), 2021-2026
18. Latin America Recombinant DNA Technology Historical Market: Breakup by Country (USD Billion), 2016-2020
19. Latin America Recombinant DNA Technology Market Forecast: Breakup by Country (USD Billion), 2021-2026
20. Middle East and Africa Recombinant DNA Technology Historical Market: Breakup by Country (USD Billion), 2016-2020
21. Middle East and Africa Recombinant DNA Technology Market Forecast: Breakup by Country (USD Billion), 2021-2026
22. Global Recombinant DNA Technology Equipment Market Structure
Key Questions Answered in the Report
The recombinant market attained a value of nearly USD 608 billion in 2020.
The market is projected to grow at a CAGR of 6.8% in the forecast period of 2021-2026.
The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach about USD 902 billion by 2026.
The recombinant DNA technology industry is being driven by rapid technological advancements owing to the growing research and development (R&D) programmes for the treatment of life-threatening diseases like cancer and diabetes.
Elimination of herbicides to produce toxic free, high-quality crops and a growing demand for a reduction in agricultural costs are augmenting market growth for recombinant DNA technology.
The major regional markets for recombinant DNA technology are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
The major products in the market are medical and non-medical. Medical Products are further divided into therapeutic agent, human protein, and vaccine. Non-medical products are further segmented into biotech crops, speciality chemicals, and others.
The significant components of recombinant DNA technology in the industry are expression system and cloning vector. Expression system is further divided into mammalian, bacteria, yeast, and baculovirus/insect.
The leading application segments of recombinant DNA technology in the industry are food and agriculture, health and disease, and environment, among others. Health and disease is further categorised into human and animal.
The significant end use sectors of the industry are biotechnology and pharmaceutical companies and academic and government research institutes, among others.
The major players in the industry are Sanofi, Amgen Inc., Genentech Inc., GenScript, and Profacgen, among others.
Analyst Review
The global recombinant DNA technology market attained a value of nearly USD 608 billion, driven by rapid technological advancements. Aided by the growing use of rDNA technology in the food and agricultural sector, the industry is further expected to grow at a CAGR of 6.8% in the forecast period 2021-2026 to reach USD 902 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. On the basis of product, the market is divided into medical and non-medical. Medical products are further divided into therapeutic agent, human protein, and vaccine. Non-medical products are further segmented into biotech crops, speciality chemicals, and others. Based on component type, the market is divided into expression system and cloning vector. Expression system is further divided into mammalian, bacteria, yeast, and baculovirus/insect. On the basis of application, the market is divided into food and agriculture, health and disease, environment, and others. Health and disease is further categorised into human and animal. Based on end use, the market is segmented into biotechnology and pharmaceutical companies, academic and government research institutions, and others. The major regional markets for recombinant DNA technology are North America, Latin America, the Asia Pacific, Europe and the Middle East and Africa. The key players in the above market are Sanofi, Amgen Inc., Genentech Inc., GenScript, and Profacgen , among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global urinalysis market attained a value of about USD 1.9 billion in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 6.8% to reach nearly USD 2.8 bil...
The global human embryonic stem cell market attained a value of nearly USD 0.7 billion in 2020, driven by the rising research and development activities and advancement in technologies. Aided by the d...
The global immunoglobulin market attained a value of about USD 11.9 billion by 2020, driven by the presence of prominent industry players. Aided by improvements in the R&D sector for treatment of vari...
The global biologics market is driven by the rising demand for microbial expression systems in the treatment of various chronic diseases. Aided by the increasing research activities to enhance the pro...
The global live cell imaging market attained a value of nearly USD 6.4 billion in 2020, driven by the growing deployment of live cell imaging in stem cell research. Aided by the rising trend of 3D pri...
NEWSLETTER